At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 335 enrolled
Drug / intervention
Novel Ibuprofen +3 moredrug
Likely dose
Novel Ibuprofen 400 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation Of The Efficacy Of A Novel Ibuprofen Formulation In The Treatment Of Post-Surgical Dental Pain: Study I
In Brief
A Phase 3 clinical trial evaluating Novel Ibuprofen, Standard Ibuprofen, and 1 other intervention for Pain. Completed, enrolled 335 participants.
Detailed Summary
This study will compare the pain relieving effect of a single-dose of a novel ibuprofen formulation to placebo and two formulations of standard ibuprofen in the treatment of post-surgical dental pain following "wisdom" tooth (third molar) removal.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2010
First PostedApr 2010
Primary CompletionJul 2010
Study CompletionAug 2010
TodayJul 2026
First PostedApr 5, 2010
Enrollment StartApr 1, 2010
Primary CompletionJul 1, 2010
Study CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.2 years ago
Interventions
Novel Ibuprofendrug
Single-dose of novel ibuprofen (equal to 400 mg ibuprofen)
Standard Ibuprofendrug
Single-dose of standard ibuprofen (400mg)
Standard Ibuprofendrug
Single-dose of standard ibuprofen (400mg)
Placebodrug
Single-dose of placebo